Results 61 to 70 of about 12,555 (213)

Candidiasis vulvovaginal recurrente

Revista Medica Sinergia, 2021
La candidiasis vulvovaginal se presenta de manera frecuente en la vida de las mujeres, incluso se ha llegado a estimar que un 75% presentaran al menos un episodio en su vida. Se presenta sobre todo en mujeres en edad reproductiva, sin ser esta una infección de transmisión sexual, sin embargo, siempre debe realizarse un diagnóstico diferencial con otras
Fernanda Ugalde González, Hector Rivera Gutierrez, María José Durán Méndez   +2 more
openaire   +2 more sources

Long‐term safety and efficacy of secukinumab in paediatric severe plaque psoriasis: 236‐week, Phase 3 trial results

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 4, Page 617-625, April 2026.
In this Phase III study, secukinumab demonstrated sustained efficacy and a favourable safety profile in paediatric patients with chronic severe plaque psoriasis over a treatment period of 236 weeks. Abstract Background Plaque psoriasis, a chronic inflammatory disease, affects up to 2.1% of the global paediatric population.
Andrzej Kaszuba, Philemon Papanastasiou, Dorota Krasowska, Raul De Lucas Laguna, Michael Ziv, Shoba Ravichandran, Amita Bansal, Swapnil S. Dahale, Ruvie Martin, Bertrand Paguet, Nina Magnolo, Kulli Kingo   +11 more
wiley   +1 more source

Genetic predisposition to a recurrent course of vulvovaginal candidiasis [PDF]

Гинекология, 2017
Vulvovaginal candidiasis (VVC) frequently occur in women of childbearing age. 5-10% of these women experience recurrent vulvovaginal candidiasis (RVVC), which is characterized by at least 4 episodes of infection in 12 months.
Sh M Pogosyan, E A Mezhevitinova, A E Donnikov, V N Prilepskaia, O V Burmenskaia, O S Nepsha, A A Bystritskiy   +6 more
doaj  

Muscle Dysfunction and Bone Loss in a Woman With Cystic Fibrosis and Obesity Treated With Glucagon‐Like Peptide 1 Agonist: A Case Report

Respirology Case Reports, Volume 14, Issue 3, March 2026.
Cystic fibrosis (CF) modulator therapies can lead to rapid and excessive weight gain. Obesity in CF can lead to undesirable metabolic complications including type 2 diabetes. Therefore, glucagon‐like peptide 1 (GLP‐1) agonists which can facilitate weight loss and improve metabolic profiles are increasingly prescribed to people with CF.
Shanal Kumar, Robyn Cobb, Angela Matson, Joseph Lee, Daniel Henderson   +4 more
wiley   +1 more source

Use of natamycin and ketoconazole suppositories in the treatment of recurrent vulvovaginal candidiasis [PDF]

РМЖ. Мать и дитя, 2018
Use of natamycin and ketoconazole suppositories in the treatment  of recurrent vulvovaginal candidiasis I.I. Ivanova1, Yu.E. Dobrokhotova2 1 Pirogov Russian National Research Medical University, Moscow, Russian Federation 2 Clinical ...
I.I. Ivanova, Yu.E. Dobrokhotova
doaj  

Epidemiology of mixed vaginitis and its management [PDF]

, 2013
Vaginitis is a common reason for visits to a health care provider, accounting for 6 million visits per year. Symptoms associated with vaginitis can cause substantial distress, resulting in time lost from work and altered self-esteem.
Galea, Therese
core  

Vaginal‐Derived Potential Probiotics and Their Postbiotics Alleviate Aerobic Vaginitis via Suppressing TLR4/MyD88/NF‐κB Signalling Pathway and Potentially Enhancing Vaginal Barrier

Microbial Biotechnology, Volume 19, Issue 3, March 2026.
Consolidated diagram of the mechanism by which L. crispatus YBR‐01, L. plantarum YBR‐01, and their postbiotics improve AV progression. ABSTRACT Antibiotic therapy is currently challenged by drug resistance and high recurrence in aerobic vaginitis (AV), making it urgent to seek novel strategies. In this study, we selected two potential probiotic strains
Meiyun Tian, Xinyi Zhang, Xuan Xu, Xia He, Xiaoyun Wu, Jing Wei, Buzhen Tan, Tingtao Chen   +7 more
wiley   +1 more source

How should you treat Candida vaginitis in patients on antibiotics? [PDF]

, 2007
Oral and intravaginal antifungals for the treatment of uncomplicated vulvovaginal candidiasis (VVC) have similar effectiveness (strength of recommendation [SOR]: A, systematic review).
Hitchcock, Kristin, Schwartz, Kendra, Xu, Jinping   +2 more
core  

Research Progress in the Treatment of Vaginitis With Bioactive Compounds: Targeting of Vaginal Microflora

MicrobiologyOpen, Volume 15, Issue 1, February 2026.
Mechanism diagram of the effect of herbal medicine on vaginitis. Herbal medicines mainly combat vaginitis by (A) inhibiting bacteria, (B) inhibiting fungi, (C) acting on the cilia of Trichomonas, (D) inhibiting virus replication, (E) repairing the mucosa, (F) enhancing immunity, and (G) maintaining the microecological balance.
Yongming Li, Huiyu Liu, Ruihan Li, Rong Li, Jiaqi Liu   +4 more
wiley   +1 more source

Probiotic‐Based Materials as Living Therapeutics

Advanced Materials, Volume 38, Issue 1, 2 January 2026.
Recent advances in Engineered Living Materials are highlighted, integrating synthetic biology and advanced materials, with a focus on probiotic‐based therapeutics. Probiotic Living Materials hold great potential for biosensing, infection treatment, osteogenesis, wound healing, vaginal and gastrointestinal disorders, and cancer therapy. breakthroughs in
Laura Sabio, Graham J. Day, Manuel Salmeron‐Sanchez   +2 more
wiley   +1 more source